Temas de la conferencia
The most anticipated event of the mRNA calendar year is back with a bang! The mRNA-Based Therapeutics Summit is returning for its 3rd year this July as the one-stop-shop for all your mRNA needs, showcasing exclusive new data from the movers and shakers in the mRNA industry. 500+ industry pioneers from the likes of the FDA, Pfizer, Moderna, BioNTech, Sanofi and many more are joining the world's only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines.
La Sociedad Científica
Hanson Wade
Observaciones
Speakers: Michiel Lodder, CEO, 20Med Therapeutics, Walter Schmidt, Director – mRNA Division, ADvantage Therapeutics, Renhuan Xu, CEO and Co-Founder, ARV Technologies, Petro Terblanche, Managing Director, Afrigen Biologics and More.
Información e inscripción:
https://go.evvnt.com/1570479-2?pid=4832
Ms. Rosie Andre
CategoríasSalud Pública, Servicios de salud